Category Archives: Stem Cell Doctors


Blood Cancer Awareness Month 2020 – Everyday Health

Professional conferences and meetings offer an opportunity for doctors, researchers, and pharmaceutical professionals to share the latest research and findings on blood cancer. Like some of the runs and walks, many conferences have been postponed or moved to a virtual setting as a result of the COVID-19 pandemic.

Upcoming conferences and meetings include:

The Leukemia & Lymphoma Society held its 2020 National Blood Cancer Conference virtually on September 12 from 11:30 a.m. to 2:45 p.m. EDT. The educational event will be open to caregivers, patients, survivors, and family members of those affected, and review treatment options, emerging therapies, and resources provided by LLS.

LSS will hold its virtual conferences on September 26 hosted by the organizations Georgia/South Carolina region and October 3, hosted by LSSs Metro New York region. Additionally, LLS will host more virtual conferences throughout October and November.

The ASH will hold it's virtual meeting December 5-8 and is the largest conference on blood-related illnesses in the world.

RELATED: New Study Sheds Light on Genetic Differences in Types of Lymphoma

See original here:
Blood Cancer Awareness Month 2020 - Everyday Health

CARLTON FLETCHER: McConnell is the poster boy for sleazy, partisan politics – The Albany Herald

Oh ... How do you sleep at night?

Ive often complained that I dont understand politics or politicians, but the truth is, I dont really want to.

I dont know what it is that makes men and women who say they want to run for office to help make their country, state, county, city a better place and then find themselves sucked into the madness that is American politics. Its a vocation that takes pretty much decent human beings and turns them into lying, cheating, double-talking cretins who make used car salesmen (no offense) look like followers of Mother Teresa.

Ive found it amazing over the years that politicians the ones who settle in for the long haul, pulling their chairs up to the pork, PAC and lobbyist troughs and just digging in like the pigs and gluttons they become think the American people are so stupid they actually believe their double-talk and bull----. By the same token, however, why would they think otherwise? The American people, who get an up-close, first-hand view of their shenanigans, keep sending them back to Washington, Atlanta, and local government agencies with hardly a second thought.

What? My elected representatives at the highest level cashed in certain stocks and bought up others after they attended a meeting that gave them advance warning of the possible impact of the coronavirus pandemic? Well, thats just good business. What, the businessman we put in the highest office in the land filed 13 bankruptcies and cheated both the American taxpayer and businesses he owed out of millions of dollars? That just shows hes got down the art of the deal, baby.

Did you say the person who wants to be president has changed his mind on important issues depending on which way the wind is blowing on a particular day so many times that he doesnt even know where he stands on those issues? Thats called playing to your base. Everyone does it.

I think Ive made it clear over the years my disdain for Kentucky Sen. Mitch McConnell. From his opposing stem cell research because the extreme right of his party opposed doctors and scientists playing God ... until someone in his family benefited from the science, to proclaiming that the entire Republican party should focus all of its efforts on making sure Barack Obama did not get a second term in office ON THE NIGHT HE WAS ELECTED, McConnell is the poster boy for lousy, self-serving, partisan politics at its worst.

As majority leader of the Senate, McConnell has spent the last 12 years the eight years that Obama was president and the four that Donald Trump has held that office doing nothing but putting conservative judges in office. McConnell conceded that the Democratic-controlled House would not go along with his right-wing agenda, so he has had the Senate do nothing but vote on judges over the last decade-plus. Other than hold a time-wasting impeachment trial that a group of power-tripping and wrong-headed Democrats dreamed up in the House, McConnell has proved to be the epitome of all that is wrong in American politics.

But the turtle man has outdone himself in his hypocritical call to replace recently passed Supreme Court Justice Ruth Bader Ginsburg before her body was even cool following her death from cancer. Wasnt it McConnell, you might ask, who led the charge to keep an Obama Supreme Court nominee from taking a seat on the high court at the end of his tenure in the White House? Yes, but see, McConnell has an answer to such charges of blatant hypocrisy and just out-right lying. He says that when Obama, a Democrat, was in office, the Senate was controlled by Republicans, so there were obvious philosophical differences. Now, with a Republican in the White House and a Republican Senate, he says, its OK.

Meaning? More political blather and bull----.

McConnell has long since proved himself a shameful self-serving opportunist whose traitorous actions in a better time would have landed him in prison or out of the government on his duff. With his disregard for Ginsburgs service, he has also shown himself to be the only passably human ghoul that only the lowest of the low aspire to. The people of Kentucky must be proud ... as they send him back to the trough to misuse and misappropriate more of our hard-earned money.

Email Carlton Fletcher at carlton.fletcher@ albanyherald.com.

See the rest here:
CARLTON FLETCHER: McConnell is the poster boy for sleazy, partisan politics - The Albany Herald

Faith for the fight: Neosho teen deals with rare combination of illnesses – Joplin Globe

Since late June, life has changed for Rylee Schroeder and her parents, Megan and Levi Schroeder.

It was then the Neosho High School senior sought help for extreme fatigue, shortness of breath, nosebleeds and more. The symptoms, combined with a previously diagnosed issue with low platelets, led Rylees pediatrician to run a series of lab tests.

The news sent the family first to Freeman Hospital West in Joplin, and then Childrens Mercy Hospital in Kansas City.

Doctors discovered Rylees low hemoglobin, platelets and white blood counts were caused by myelodysplastic syndrome. Additional testing revealed the teen has an extremely rare congenital disorder called Shwachman-Diamond syndrome and a TP53 gene mutation that led to the MDS.

Megan said her daughter is only the 36th patient known to have this combination of illnesses, which have progressed to bone marrow failure.

On Friday, Rylee received a stem cell bone marrow transplant at Childrens Mercy in Kansas City, thanks to a donation from her 12-year-old brother Colin.

Megan said her son was a 12/12 match for Rylee. Typically, doctors look for a 10/10 match, or a 5/5 match with a parent. The Be a Match Donor Registry located four 10/10 matches, two donors in the United States and two international donors.

If everything goes well with the transplant, doctors hope to see Colins stem cells begin to take hold in Rylees body between Day 14 to Day 21, post transplant.

Relying on faith

Through everything, Rylee and her family are relying on their faith, as well as support from friends at Racine Christian Church and within the community of Neosho, to get them through the tough days.

We are lucky to have a great church and thankful Sunday serves are online on Facebook, Megan said. We may not be there, but we still feel a part of it, and they are always ready to lift us up.

Many times, Ive thought Im not strong enough to do this, but Im reminded that I am. We are so tired and weary but (God) has us.

Megan said shes used to being the one to offer help through giving and volunteering. Now their family is on the other side, leaning on the support of others.

Our faith means everything to us, Megan said. Without it, we wouldnt be doing as well as we are. Its hard enough as it is. If you dont have something to believe in with your whole heart to guide you and lean on, you would just be lost. It would be overwhelming to take it on yourself.

More about Rylee

Rylee, who turned 17 shortly after her diagnosis, is active in the NHS show choir, choir, Key Club and FCA.

A member of the Racine Christian Church youth leadership team, she was also slated to go to Ireland this summer pre-pandemic with the churchs mission team.

This past Thursday, Rylee was highlighted at the NHS volleyball game for childhood cancer awareness month. On Friday, she was recognized at the home football game.

Members of her show choir helped start a Go Fund Me account earlier this summer to help the family with travel expenses to and from Kansas City. Her youth minister has since created another one to help with the coming months.

Megan said the family always helps at Solomons Dance Studio recitals because the owner, Charity, uses the lessons to teach children to love dance and to love others as well as themselves.

Rylee was able to to attend the recital to watch her sister Erin dance. On the last day of the recital, Charity asked the entire family to come forward, offering prayers over the entire situation.

Rylees small group from the church, which meets on Wednesday evenings, livechats with her, allowing the teen to continue to be part of the discussions.

Before Rylee was admitted to begin the chemo needed prior to the transplant, she asked to rededicate her life to Christ. Megan said she wanted to feel his strength renewed as she went into the fight.

Our close friends all stayed behind after church that Sunday, even though it was last minute, to be witness to her baptism, Megan said. They are some of our strongest supporters. We would be lost without them.

Megan said those friends, steeped in faith, give her strength to sit at the hospital, holding Rylees hand.

I can reach out to any of them to start praying with me to help make me feel stronger when I feel I am failing her, Megan said. I know Gods got this. He is strong all the time even when we can not be strong.

Biblical baubles

Many of Rylee Schroeders friends are wearing a Rally behind Rylee bracelet featuring Isaiah 41:10: So do not fear, for I am with you; do not be dismayed, for I am your God. I will strengthen you and help you; I will uphold you with my righteous right hand.

A family friend made them to distribute to members of the community. A limited number remain. Information about the bracelets, and Rylees journey, may be found on a Facebook page, Rally Behind Rylee.

Read this article:
Faith for the fight: Neosho teen deals with rare combination of illnesses - Joplin Globe

RCSI partnership aims to advance predictive tests for common blood cancer – Siliconrepublic.com

RCSIs new partnership with Skyline Dx will combine genomics testing and next-generation sequencing tech with the goal of advancing predictive tests for multiple myeloma.

The Royal College of Surgeons in Ireland (RCSI) has announced a new partnership led by the universitys researchers that aims to advance predictive tests for multiple myeloma, which is the second most common blood cancer in Ireland.

The study, which combines genomic testing and next-generation sequencing technology, will be carried out at Beaumont Hospital in Dublin, and will be run through Blood Cancer Network Ireland, with several other cancer hospitals in Ireland participating.

It represents a collaboration between RCSI University of Medicine and Health Sciences and biotech company Skyline Dx, with funding support from Amgen, Bristol Myers Squibb company Celgene, and Janssen.

Multiple myeloma is a cancer of plasma cells in the bone marrow that normally produce antibodies to help fight infection. Approximately 250 patients are diagnosed with this condition in Ireland each year.

Due to the complex nature of the disease, patients often require multidisciplinary medical input and myeloma drugs are among the highest cost therapies worldwide, according to RCSI. The outlook for patients has greatly improved with newer treatments, but it is still considered an incurable disease.

According to RCSI, predicting the course of the disease and guiding treatment choice in newly diagnosed patients is one of the major challenges that comes with this form of cancer.

One test that can help predict patient outcomes is the minimal residual disease test, which is performed on the patients DNA at diagnosis with next-generation sequencing. This can detect if there are trace amounts of the cancer remaining in a patient after treatment and has shown to be predictive of long-term outcomes in several studies.

Another test has been developed by SkylineDx, which uses a novel gene-expression-based test to guide prognosis, called the MMprofiler.

At Beaumont and RCSI, in collaboration with SkylineDx, scientists have implemented these gene-based tests to guide prognosis.

The study aims to combine these two highly predictive modalities to provide a personalised medicine approach for patients. It establishes if patients have a high risk of relapsing and has been increasingly adopted in global clinical trials as a more predictive and robust marker than older tests.

RCSI said that in-depth analysis of genetic risk could enable doctors to identify which patients are at high-risk of relapse after a stem cell transplant. With this knowledge, it may be possible to refine treatment for individual patients based on their specific disease molecular signature.

Dr Siobhan Glavey, honorary senior lecturer at RCSI and consultant haematologist at Beaumont, is acting as the projects principal investigator.

If our study can definitively determine which patients will benefit from certain treatments, and when, it will provide clinicians with invaluable information that will lead to better outcomes for patients with multiple myeloma, she said.

As we move towards personalised medicine, studies like ours will hopefully become more and more common and will help to target high-cost effective therapies with greater precision. The study will initially enrol a small number of patients and follow them over time to test this theory.

Read the original:
RCSI partnership aims to advance predictive tests for common blood cancer - Siliconrepublic.com

The Holistic Sanctuary Announces Exciting Plans to Expand Over Next 4 Years and Save More Lives – thepress.net

BEVERLY HILLS, Calif., Sept. 19, 2020 /PRNewswire/ -- The Holistic Sanctuary is proud to announce its exciting plans to grow the number of cutting-edge luxury centers it has over the next four years, allowing it to help even more patients in need of its pioneering treatments.

After a decade of revolutionizing the holistic health field and saving lives, The Holistic Sanctuary, which currently has a state-of-the-art facility in Baja California (Mexico), plans to open another center in Tulum, Mexico, as well as an additional three centers in several other locations around the world.

Holistic Sanctuary Tulum is well on its way to opening its doors in 2021, which will be followed by plans to open other centers in Tulum (2021), Malibu (2022), London (2023) and Dubai (2024).

The Holistic Sanctuary is a world-class holistic medical spa that uses cutting-edge technology and advanced therapies from around the world to cure, heal, and reverse illnesses and diseases that Western medical professionals have said are incurable. By using a combination of natural therapies, they help people to recover from a variety of different conditions such as depression, addiction, PTSD, stress, anxiety, and more.

Johnny Tabaie, CEO and Founder of The Holistic Sanctuary, said:"We are incredibly excited that we will soon be able to help even more patients around the world. We've taken holistic healing to a whole different level, and our intention has always been to heal patients using natural, effective, holistic and other alternative therapies that give results in real-time, without having to medicate people with addictive drugs.

"We simplytransform people's lives; we give them a fighting chance at a good quality oflife. We get people off prescribed medications, heal the underlying cause of PTSD, depression, trauma and even addiction, then send them back home healthy, thriving, happy and whole again."

More information on The Holistic Sanctuary's luxury drug rehab centers can be found at https://www.theholisticsanctuary.com/luxury-rehab-centers/

In addition to its growth plans, the organization has also announced that by the end of 2020 it will have the first AIDS and cancer research center that will strive to cure diseases like this using revolutionary stem cell technology. It will also be able to treat other autoimmune conditions such as lupus, rheumatoid arthritis, Lyme disease, neuropathy, multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS).

This kind of cutting technology has been around for the last 30 years, revolutionizing how illnesses like these are treated through the discovery of isolated stem cell genes that have been proven clinically to showit has cured two patients suffering from AIDS and cancer. One has been clear for 10 years now, with the other being cured last year. This is a new, paradigm-shifting approach that is pushing western medication treatment to the side.

To learn about how stem cell technology is used by the centers, more information can be found here: https://www.theholisticsanctuary.com/stem-cell-therapy/

Learn more about The Holistic Sanctuary's Mexico stem cell center here: https://www.theholisticsanctuary.com/stem-cell-therapy/mexico/

The Holistic Sanctuary has an 80% success rate at healing patients that are either on medications, alcohol, street drugs, or suffer from mental health disorders such as PTSD, depression, anxiety and trauma. See more information on what treatments are used for these:

"We've incorporated holistic medicine and methodically weaved it with sacred plant medicine to have a better synergistic never before seen outcome. In the last 10 years, we have therapeutically, safely and humanely given people sacred plant medicines like Ibogaine, DMT, Changa, 5-MEO, Kambo, Psilocybin, mushrooms, and much more,"added Tabaie.

The organization is looking for investors and partners to help finance and push this revolutionary vision forward. For more information about The Holistic Sanctuary and investor relations, please send an email or call +1-310-601-7805 or visit their website at http://www.theholisticsanctuary.com.

About The Holistic Sanctuary

The Holistic Sanctuary is a world-class holistic medical spa that uses cutting-edge and advanced therapies from around the world. It uses powerful modalities to cure, heal, and reverse illnesses and diseases that Western medical professionals have said are incurable. It is not a drug rehab, more along the lines of a luxury treatment center that transforms lives. It helps people to recover from depression, any type of addiction, PTSD, stress, anxiety, as well as other mental health problems. The centers use a combination of natural therapies to help people recover mentally, physically and emotionally. Unlike mainstream doctors, rehabs, and treatment centers, The Holistic Sanctuary avoids the use of outdated theories, ineffective therapies and addiction to toxic medications and drugs. Instead, it addresses the root causes of these illnesses, improves physical and mental health and alleviates the illnesses.

Media Contact

Company Name: The Holistic Sanctuary

Contact Person: Investor Relations

Email: info@theholisticsanctuary.com

Phone: +1-310-601-7805

Address: 1212 Wilshire Blvd.

City:Beverly Hills

State:California

Website: http://www.theholisticsanctuary.com

Related Images

the-holistic-sanctuary.png The Holistic Sanctuary Most Exclusive Healing Center In The World, The Holistic Sanctuary Healing Center Offers Holistic Stem Cells, Plant Medicine and Powerful Therapies for Lupus, Lyme, MS, ALS, Addiction, Depression, PTSD, Stem Cell Therapies to Heal Clients Naturally

Related Video

Read more from the original source:
The Holistic Sanctuary Announces Exciting Plans to Expand Over Next 4 Years and Save More Lives - thepress.net

Odessa woman hopes to gain back her sight after 6 years of being blind – NewsWest9.com

"It was like a curtain dropping over your eyes when youre going into the dark," Debbie Ramirez, Odessa resident said.

ODESSA, Texas Debbie Ramirez wakes up every morning just like you and I do.

She brushes her hair, like you and I do. She puts on mascara.

And then she puts on her shoes, just like you and I do.

Except, she doesn't get ready the way you and I do. That's because Debbie Ramirez is blind.

"I can see me moving my hand right in front of me, but right here I don't see anything," Debbie Ramirez, Odessa resident said.

It was six years ago when Debbie's life changed.

"It was like a curtain dropping over your eyes when you're going into the dark," Ramirez said.

That darkness not only took her sight. Debbie lost 75% of her memory and with it most of her life.

For years she sought out help from doctors. But none had an answer.

"They all told me they didn't know why I went blind. Nobody could explain it," Ramirez said.

"I thought how am I going to live like this? I've seen my entire life, I don't know how to live blind," Ramirez said.

Then one day, a phone call changed her life once again.

"I had a very large tumor. It was the size of an orange," Ramirez said.

An Odessa doctor finally had an answer. But what would come next was worse than you could imagine.

"He rushed me to Dallas by ambulance because he said I had less than 30 days to live," Ramirez said.

Her thoughts went straight to her family.

"My children are everything," Ramirez said.

And what would happen if she didn't make it through the surgery?

But the surgery was a success. The tumor was gone.

"I was me again and I just wanted to move on with life and grasp it because I had been given a second chance," Ramirez said.

Her memory started to come back, the pain and the headaches faded away, and Debbie began to take charge of her life again.

She re-learned how to cook, clean and even how to do laundry.

And now Debbie has a chance to get her sight back through a clinical trial in Florida.

"I am just really hoping to get my sight back more than anything. It's been the hardest thing I've ever gone through," Ramirez said.

The trial would use neurons from bone marrow to generate new stem cells in her retina and optic nerves. But there's one more roadblock before Debbie can see her children and grandson.

"It's a lot of money and my insurance will not cover it because it has to do with stem cell therapy," Ramirez said.

But Debbie said she's not giving up.

Although Debbie can't see, she says one thing is clear to her.

"I feel like God has always been beside me," Ramirez said.

________________________________________________________________

If you'd like to help Debbie with her mission to get her sight back, you can reach out to her directly at 432-212-5726.

She said she will take any help she can get!

Go here to read the rest:
Odessa woman hopes to gain back her sight after 6 years of being blind - NewsWest9.com

Highland family from Alness pleads for potential donors to come forward to help ill toddler – Inverness Courier

Adeline Davidson and dad Jordan. Picture: Callum Mackay

A global search for the perfect match for Adeline Davidson earlier this year threw up the name of a woman in the United States considered to be the best possible option.

But her mum Stephanie has spoken of her heartbreak after being told this week there are no longer any donors available for her seriously ill daughter.

She is now begging anyone who will listen to sign up to become stem cell or bone marrow donors.

Adeline, who will be four in November, has a rare form of blood cancer and doctors believe a stem cell match is her best chance.

Close matches had been found from potential donors signed up to registers, but the ongoing coronavirus crisis has ruled them out.

The devastating news was shared with the Alness family this week by the Glasgow-based consultant they have been working with.

Ms Davidson said: After almost two years, were back to square one. We were waiting for a specific donor.

In a three-minute phone call, that whole two years was taken away. She needs a transplant to live any sort of life.

I cant put into words how heartbroken we are after finding out Adeline no longer has a donor available and we are back to hoping, praying and searching for a match to save our daughters life.

After almost two years of waiting for this life-saving treatment, we have to wait even longer but this time with less hope.

As it stands, there are no longer any matches on the registry for Adeline and as you can imagine its going to leave us with some dreadful decision-making in a situation thats already life or death.

That is unless we find another match for our sweet, funny, sassy, beautiful little girl.

We cant beg or plead enough to please sign up to become a stem cell/bone marrow donor. Its a different registry from organ donation.

Please go to DKMS UK website or Anthony Nolan and register. Adeline needs a lifesaver.

Click here for more news

Get a digital copy of the Inverness Courier delivered straight to your inbox every week and read the full newspaper on your desktop, phone or laptop.

View post:
Highland family from Alness pleads for potential donors to come forward to help ill toddler - Inverness Courier

Global Multiple Myeloma Treatment Market-Industry Analysis and forecast 2019 2027: By Application, Type, and Region. – Galus Australis

Global Multiple Myeloma Treatment Marketsize was valued US$ XX Mn. in 2019 and the total revenue is expected to grow at 11.34% from 2019 to 2027, reaching nearly US$ XX Mn.

The report study has analyzed the revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers, and market disrupters in the report, and the same is reflected in our analysis.

Multiple myeloma, also known as Kahlers disease, is a type of blood cancer of plasma cells that are found in the bone marrow. Multiple myeloma causes cancer cells to accrue in the bone marrow, where they attack the strong blood cells.

Multiple myeloma treatments have developed significantly above the last decade. New multiple myeloma treatments have provided efficient survival rates between myeloma patients. It has been also observed that the future drug pipeline of multiple myeloma is promising, biological drugs and stem cell-based therapies are likely to fuel the multiple myeloma treatment market in the upcoming years. On the other hand, the costs of radiotherapeutic equipment implementation, a limited number of target patients population, strict legal regulations are expected to hamper the market growth. Likewise, the MMR report contains a detailed study of factors that will drive and restrain the growth of the multiple myeloma treatment market globally.

Multiple Myeloma accounts for approximately 2.5% of the cancer-related deaths globally and is the second most major type of blood cancer next to Hodgkins Lymphoma. According to the World Cancer Research Fund, in 2018, above 159500 cases of multiple myeloma were diagnosed with the condition, where the occurrence rate among women and men was found in the ratio 1.2:1. The onset of the disease occurs after the age of 60. In recent times, the age of onset is drastically decreasing. In the year 2001, only two medications were available for treating multiple myeloma but now in 2020, 18 medicines are available. Moreover, there are over 25 FDA-approved drugs for treating multiple myeloma with therapeutics such as pomalidomide, carfilzomib, panobinostat, and ixazomib. The availability of new medications has given new hope for better treatments and better results and thus affecting the growth of the market as well. However, the survival of patients with a limited response while receiving treatment with primary immunodeficiency therapy remains poor and is one of the major challenges.

The MMR report covers the segments in the multiple myeloma treatment market such as type and application. By application, the hospital is expected to continue to hold the largest XX.85% share in multiple myeloma treatments market thanks to growing specialist doctors providing the best chance of long term survival.

North Americas multiple myeloma treatments market was valued at US$ XX.26 Mn. in 2019 and is expected to reach a value of US$ XX.13 Mn. by 2027, with a CAGR of 9.3%. The number of patients in the U.S is growing YoY with nearly 14600 new cases diagnosed annually. In 2017 alone there were approximately 142000 patients diagnosed for multiple myeloma.

Europe and the South African population are prone to develop multiple myeloma when compared with Asian economies. Though, the population in the APAC region outwits Europe and Africa. Further, growing the adoption rate of novel therapies, coupled with the support from the government along with non-government organizations and improving the survival of multiple myeloma patients.

The research study includes the profiles of leading players operating in the global multiple myeloma treatment market. Eli Lilly Company acquired ARMO Biosciences to develop immunotherapies for the treatment of cancer, hypercholesterolemia, inflammatory, and fibrosis diseases.

The objective of the report is to present a comprehensive analysis of the Global Multiple Myeloma Treatment Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Multiple Myeloma Treatment Market dynamics, structure by analyzing the market segments and projects the Global Multiple Myeloma Treatment Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Multiple Myeloma Treatment Market make the report investors guide. Scope of the Global Multiple Myeloma Treatment Market

Global Multiple Myeloma Treatment Market, by Applications

Hospitals Clinics Cancer Treatment and Rehabilitation Centers Global Multiple Myeloma Treatment Market, by Type

Proteasome Inhibitors Immunomodulatory Agents (IMiDs) Histone Deacetylase (HDAC) Inhibitors Immunotherapy Cytotoxic Chemotherapy Global Multiple Myeloma Treatment Market, by Region

Asia Pacific North America Europe South America Middle East & Africa Key players operating in Global Multiple Myeloma Treatment Market

Celgene Corporation Janssen Biotech, Inc. Bristol-Myers Squibb Company Novartis AG Cellectar Biosciences Inc. Millennium Pharmaceuticals Amgen, Inc. bbVie Genzyme Corporation Juno Therapeutics Eli Lilly and Company Glenmark Pharma

Global Multiple Myeloma Treatment Market Request For View Sample Report Page : @https://www.maximizemarketresearch.com/request-sample/65671 About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info: Name: Vikas Godage Organization: MAXIMIZE MARKET RESEARCH PVT. LTD. Email:[emailprotected] Contact: +919607065656 / +919607195908 Website:www.maximizemarketresearch.com

The rest is here:
Global Multiple Myeloma Treatment Market-Industry Analysis and forecast 2019 2027: By Application, Type, and Region. - Galus Australis

Editorial: UT Health’s new teaching hospital will boost region – Laredo Morning Times

Express-News Editorial Board

Dr. William L. Henrich, president of UT Health San Antonio, said a new teaching hospital will complement what is currently offered at University Hospital.

Dr. William L. Henrich, president of UT Health San Antonio, said a new teaching hospital will complement what is currently offered at University Hospital.

Dr. William L. Henrich, president of UT Health San Antonio, said a new teaching hospital will complement what is currently offered at University Hospital.

Dr. William L. Henrich, president of UT Health San Antonio, said a new teaching hospital will complement what is currently offered at University Hospital.

Editorial: UT Healths new teaching hospital will boost region

A planned 144-bed teaching hospital on the UT Health San Antonio campus slated to open in the spring of 2024 will boost enrollment for many health programs so crucial for the region and state.

The medical school alone could see an increase of 22 students in each enrollment class. The number of medical residents could grow by 100 to 130 slots by 2027. Currently, 1,000 residency slots are offered through UT Health San Antonio.

This is great news for medical and other students training for health professions who want to complete their education in Texas. It will help address the shortage of providers in Bexar County and across the state. Historically, many doctors remain in the communities where they complete their medical training.

The San Antonio hospital would become the fourth operated by the University of Texas System. The others are in Dallas, Galveston and Tyler.

Most of the UT System health science centers have partnerships with independently managed hospitals in their communities.

Most new hospital projects arrive with much fanfare. This project has been quietly moving along over the past year with little public awareness or discussion.

The University of Texas System regents last month placed the nearly $400 million project on its capital improvement program and are expected to appropriate construction funds at their November meeting.

The hospital will be located on 12 acres in the South Texas Medical Center provided by the San Antonio Medical Foundation. The eight-story hospital will be adjacent to the Mays Cancer Center, formerly known as the Cancer Therapy and Research Center. The jointly run UT Health San Antonio-MD Anderson program is a National Cancer Institute-designated research center. The hospital and the cancer center will be connected by a skybridge.

A 530-space parking garage is also included in the project.

Background information provided to the regents describes a high-acuity hospital offering treatment programs in cancer, neurosciences, orthopedics, urology, thoracic surgery and bariatrics.

A distinct, competitive advantage of the hospital will be the unique leading-edge therapies and early-phase clinical trials in the many disciplines in which the university has expertise, including immunologic and stem cell therapies in oncology and diabetes, the backgrounder states.

The construction of a second teaching hospital in San Antonio raises concerns about the multibillion-dollar investment taxpayers have made in the Bexar County Hospital District, which includes University Hospital and some two dozen University Health System clinics.

University Hospital has long been the primary teaching hospital for UT Health San Antonio, and much of its recent expansion including the new 400-bed Womens and Childrens Hospital now under construction alongside University Hospital has been in large part to accommodate the patients seen by UT Health San Antonio doctors.

Will the two be duplicating services and competing for patients?

UT Health San Antonio President William L. Henrich and Bexar County Judge Nelson Wolff said the two hospitals will work in partnership. The hospital district and UT officials are negotiating a memorandum of understanding to that effect, Wolff said.

Henrich said the new hospital will not replicate any services and will complement what is currently offered. He said the new facility will allow for the expansion of the health science centers three primary missions clinical care, biomedical research and education.

Our clinical practices have been growing 8 to 10 percent a year, Henrich said. We have about $300 million in research on campus, and we need more access to clinical trials. Sophisticated clinical trials in cancer, rheumatology, gastroenterology and this hospital will afford us the opportunity to carry out those trials, and that will be a unique feature of this hospital.

In addition, the new hospital is expected to create 750 to 850 new jobs.

This is an important project for San Antonio and Texas. It will expand higher education opportunities, help address the doctor shortage in the state and provide a lift to the local economy by creating skilled jobs.

We look forward to a thriving partnership between UT Health and the University Health System.

Continued here:
Editorial: UT Health's new teaching hospital will boost region - Laredo Morning Times

Mum’s message to the complete stranger who saved her son’s life – LincolnshireLive

A mum says the surprise baby she feared she would lose because of a rare genetic disorder is now living a normal life thanks to a bone marrow transplant from a complete stranger.

Former clinical psychologist Zoe Alderson has told how her son Henry was diagnosed with a rare genetic disorder, affecting just 125 people in the UK meaning he needed monthly blood transfusions.

But everything changed in April 2019 when Henry who has Diamond Blackfan Anaemia (DBA), which is caused by the bone marrow failing to produce red blood cells received a successful bone marrow transplant.

Zoe, 33, of Harwich, Essex, said he went from relying on transfusions to stay alive to having the blood count of a normal child his age, adding: We have no idea who provided the bone marrow, but not a day goes by when we dont think about that person. We will be forever in their debt.

At one point, it felt like we would never have a normal life, now you cant tell Henry apart from any other happy four-year-old.

Zoes own health problems began with fatigue, headaches and irregular periods throughout her teens.

But, in 2004, when she saw her doctor after her breasts began lactating, a blood test revealed she had higher than normal levels of the hormone prolactin. Amongst other things, it encourages the growth of breasts and lactation during pregnancy.

I didnt have a clue what was wrong with me, she explained.

I wrote it off as being stressed and nothing more.

Referred to Colchester Hospital in Essex in November 2004, an MRI scan revealed she had a benign 1cm tumour on her pituitary gland, at the base of her brain and was put on a prolactin inhibitor which she still takes to this day and, within six months, the tumour shrank to 3mm.

Doctors told me it was classed as a brain tumour, but I didnt need to panic, she continued. They said I might face some difficulty getting pregnant, though.

My periods were so irregular afterwards, that I never expected to conceive.

I wasnt that bothered, either, as I was just happy to be told the tumour was benign.

Meeting her husband Craig, 40, a graphic design company manager, at a work Christmas do in December 2007, within a year they moved in together.

But, firmly on a career path, they flew to Mombasa, Kenya, for an intimate wedding with their nearest and dearest on March 17, 2010 and thoughts of having children could not have been further from their minds.

Zoe said: We really werent fussed, or thats what we told ourselves.

She continued: We were both career driven and in our prime. Wed never even discussed the possibility of IVF or adoption it just wasnt on the radar.

But all that changed in January 2015, when Zoe was plagued with morning sickness.

I hadnt had a period for years, she said.

But Id been sick for a solid few days.

She continued: At first, I dismissed it as a bug, but when it lasted over a week, I thought I should do a pregnancy test before I saw a doctor.

I picked one up from the supermarket and when it came back positive, I just sat in the bathroom having a bit of a cry.

It was such a shock, it was just crazy.

She continued: Craig was absolutely thrilled, though, for someone who had said he wasnt fussed about having a baby.

But soon Zoe was haunted by the feeling that something wasnt right, with the pregnancy.

Then, at the 12-week scan, in early April 2015, the couple were told their baby showed signs of a genetic defect and was unlikely to survive to full-term, after finding a worrying amount of fluid around his head which is often an indicator of chromosomal defects in a foetus, according to the NHS.

Zoe said: Craig, ever the optimist, was convinced wed walk in and everything would be fine and dandy.

But moments after finding the heartbeat, the womans face dropped and before I knew it there were five medics huddled around the screen looking at the scan.

We were asked to wait down the corridor where doctors explained there was a high chance the baby had a genetic defect and was unlikely to survive for two more weeks.

Given chorionic villus sampling (CVS) a prenatal test to detect birth defects after three days the results came back negative for the most common conditions, but further testing for rarer defects left the expectant parents playing an agonising waiting game.

It felt like we had already written off our baby at that point, said Zoe.

We were carrying out the testing as an insurance policy, to see if there was a chance we could pass on any faulty genes in the future.

She continued: We were offered a termination but decided to let nature take its course.

And nature clearly had a positive plan for their baby boy, who continued to grow at a healthy rate.

We hit 14 weeks, then 20, then 24 and somehow we even made it to 36 weeks, Zoe said.

She continued: We still didnt have the results back from the genetic screening, but making it so far surprised everyone.

The consultant was amazed, he said hed never seen such a poorly foetus survive to this point.

But, just days after the milestone scan, Zoe could not feel the baby moving and rushed to Colchester Hospital, where a scan showed he was in distress.

Concerned, doctors performed an emergency C-section, delivering baby Henry on November 20, 2015.

When Henry was born we didnt know what was wrong with him still, said Zoe.

He let out a cry, but was ghostly white and was rushed to neonatal intensive care.

His pale complexion meant doctors assumed Henry had suffered from a placental haemorrhage in the womb, with a blood test showing he had a low red blood cell count.

Placed in an induced coma, the tot spent three weeks in intensive care, receiving three blood transfusions, to build up his red blood count.

I didnt get to see him on the day he was born, Zoe recalled. But I sent Craig down right away to keep an eye on him.

She continued: After the blood transfusions, he looked like a proper baby again and I couldnt wait to get him home.

Discharged at the beginning of December, the new parents were told to bring Henry in at the first sign of anything unusual.

He screamed around the clock and would not take to the bottle, but it was only when Henry turned deathly pale, on Christmas Eve, that the couple rushed him back to the hospital, where further tests revealed his red blood cell count was dangerously low leading to another transfusion.

For the next three months, every month, the couple would return to the hospital for Henry to receive a blood transfusion until, at four months old, he had a bone marrow biopsy.

Up until that point, all they could tell us was that Henry was anaemic, but that they didnt know why, Zoe explained.

The consultant examined the biopsy straight away and said it looked like he had DBA.

She continued: It was the first time wed heard of it, but as soon as we got home and Googled it, wed basically diagnosed Henry ourselves.

Two months later, by then six months old, his CVS results made the diagnosis official.

And, from then onwards, little Henry needed a blood transfusion every month with doctors telling his parents this would continue for the rest of his life.

Zoe said: It felt like Groundhog Day. After the transfusion hed be full of energy and behaving like a normal child.

But slowly, as the days passed, you could literally see the life draining out of him.

It sounds awful, but by the end of the month he really did look dead.

When he reach 18 months old, the couple were told Henrys body was suffering from an iron overload, because of his numerous blood transfusions.

To avoid iron poisoning which can cause severe damage to major organs he began taking iron chelation drugs, to remove the excess mineral from his body.

Administered through an IV, which Henry was hooked up to every night, Zoe said: It was such a difficult period for us.

She continued: It was bad enough seeing him deteriorate each week, without having to start sticking a needle into him every night as well.

He hated it at the time, but was fine during the day. Looking back, he was remarkably brave.

But when Zoe was told in February 2019 that he would need to be hooked up to the iron chelation machine 24 hours a day, she put her foot down.

Thats when I drew the line, she said. It wasnt fair expecting that of a child and I said I wanted them to look into alternatives.

Thats when doctors said Henry would be eligible for a bone marrow transplant.

After that, by then aged three, things moved quickly and, just six weeks later, Henry was matched with a tissue donor.

Then, in the last week of April 2019, he had chemotherapy to wipe out his existing bone marrow, before having a central line fitted, allowing the new stem cells to pass through his blood stream.

Put on immunosuppressants a type of medicine which stop the body from rejecting donor tissue for 12 months, Zoe said she witnessed a miracle, as she slowly got her boy back.

He hasnt needed a blood transfusion since he had the bone marrow donation, she said. Hes a completely different child.

She continued: Hes full of energy around the clock now not just for a few days a month.

I dont think we realised just how poorly he had been for the last four years until he recovered. That had become our normal.

Taken off immunosuppressants in May 2020, a month later, blood tests revealed that Henry had the blood count of an average four-year-old.

For his whole life hes been in and out of hospital and now, finally, he can start to live like any other kid, said Zoe.

Ringing the end of treatment bell was such a big deal for all of us.

It felt like the end of that chapter in our lives.

Desperate to raise awareness of DBA and the importance of bone marrow donation, Zoe now has an important message she wants to send to whoever saved her sons life.

Were so grateful to whoever it was that donated their bone marrow for Henry, she said.

To anyone else out there who isnt on the donor register, please sign up.

She continued: All it takes is a bit of your spit sent in the post and it could quite literally save someones life.

Go here to read the rest:
Mum's message to the complete stranger who saved her son's life - LincolnshireLive